换一批
换一批Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.
作者：
主题词
老年人(Aged);雄激素拮抗药(Androgen Antagonists);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);综合疗法(Combined Modality Therapy);无病生存(Disease-Free Survival);用药计划表(Drug Administration Schedule);雌氮芥(Estramustine);可行性研究(Feasibility Studies);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);紫杉酚(Paclitaxel);前列腺特异抗原(Prostate-Specific Antigen);前列腺肿瘤(Prostatic Neoplasms)
DOI
10.1002/cncr.23910
PMID
18989865
发布时间
2015-11-19
- 浏览122
Cancer
3137-45页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
